TitleChemoprotection by sulforaphane: keep one eye beyond Keap1.
Publication TypeJournal Article
Year of Publication2006
AuthorsMyzak MC, Dashwood RH
JournalCancer Lett
Volume233
Issue2
Pagination208-18
Date Published2006 Feb 28
ISSN0304-3835
KeywordsAnticarcinogenic Agents, Cell Cycle, Humans, Intracellular Signaling Peptides and Proteins, Isothiocyanates, Kelch-Like ECH-Associated Protein 1, Neoplasms, Proteins, Signal Transduction, Thiocyanates
Abstract

Sulforaphane (SFN) is an isothiocyanate found in cruciferous vegetables, with particularly high levels detected in broccoli and broccoli sprouts. Over a decade ago, this phytochemical was identified as a likely chemopreventive agent based on its ability to induce Phase 2 detoxification enzymes, as well as to inhibit Phase 1 enzymes involved in carcinogen activation. Considerable attention has focused on SFN as a 'blocking' agent, with the ability to modulate the Nrf2/Keap1 pathway, but recent evidence suggests that SFN acts by numerous other mechanisms. SFN induces cell cycle arrest and apoptosis in cancer cells, inhibits tubulin polymerization, activates checkpoint 2 kinase, and inhibits histone deacetylase activity. The latter findings suggest that SFN may be effective during the post-initiation stages of carcinogenesis, as a 'suppressing' agent. Moreover, pharmacological administration of SFN may be a promising therapeutic approach to the treatment of cancers, including those characterized by increased inflammation and involving viral or bacterial-related pathologies. The present review discusses the more widely established chemoprotective mechanisms of SFN, but makes the case for additional work on mechanisms that might be of importance during later stages of carcinogenesis, beyond Keap1.

DOI10.1016/j.canlet.2005.02.033
Alternate JournalCancer Lett.
PubMed ID16520150
PubMed Central IDPMC2276573
Grant ListP01 CA090890 / CA / NCI NIH HHS / United States
P01 CA090890-01A20003 / CA / NCI NIH HHS / United States
P30 ES00210 / ES / NIEHS NIH HHS / United States
R01 CA080176 / CA / NCI NIH HHS / United States
CA90890 / CA / NCI NIH HHS / United States
CA80176 / CA / NCI NIH HHS / United States
P01 CA090890-05 / CA / NCI NIH HHS / United States
R01 CA065525 / CA / NCI NIH HHS / United States
R01 CA065525-08 / CA / NCI NIH HHS / United States
R01 CA065525-09 / CA / NCI NIH HHS / United States
CA66525 / CA / NCI NIH HHS / United States
R01 CA080176-05 / CA / NCI NIH HHS / United States
P01 CA090890-01A29001 / CA / NCI NIH HHS / United States
P30 ES000210 / ES / NIEHS NIH HHS / United States